95 related articles for article (PubMed ID: 27491000)
1. Corrigendum to 'Ca
Chai S; Qian Y; Tang J; Liang Z; Zhang M; Si J; Li X; Huang W; Xu R; Wang K
Cancer Lett; 2016 Oct; 380(2):609-610. PubMed ID: 27491000
[No Abstract] [Full Text] [Related]
2. Retraction notice to "Ca2+/Calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer" [Cancer Lett. 344(1) (2014) 119-128].
Chai S; Qian Y; Tang J; Liang Z; Zhang M; Si J; Li X; Huang W; Xu R; Wang K
Cancer Lett; 2018 Feb; 414():312. PubMed ID: 29277380
[No Abstract] [Full Text] [Related]
3. RETRACTED: Ca(2+)/calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer.
Chai S; Qian Y; Tang J; Liang Z; Zhang M; Si J; Li X; Huang W; Xu R; Wang K
Cancer Lett; 2014 Mar; 344(1):119-128. PubMed ID: 24189456
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interleukin-1beta -induced NF-kappa B activation by calcium/calmodulin-dependent protein kinase kinase occurs through Akt activation associated with interleukin-1 receptor-associated kinase phosphorylation and uncoupling of MyD88.
Chen BC; Wu WT; Ho FM; Lin WW
J Biol Chem; 2002 Jul; 277(27):24169-79. PubMed ID: 11976320
[TBL] [Abstract][Full Text] [Related]
5. Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells.
Chai S; Xu X; Wang Y; Zhou Y; Zhang C; Yang Y; Yang Y; Xu H; Xu R; Wang K
Oncotarget; 2015 Jun; 6(18):16069-83. PubMed ID: 25965829
[TBL] [Abstract][Full Text] [Related]
6. Ca2+/calmodulin-dependent kinase II contributes to inhibitor of nuclear factor-kappa B kinase complex activation in Helicobacter pylori infection.
Maubach G; Sokolova O; Wolfien M; Rothkötter HJ; Naumann M
Int J Cancer; 2013 Sep; 133(6):1507-12. PubMed ID: 23463379
[TBL] [Abstract][Full Text] [Related]
7. Targeting the KRAS, p38α, and NF-κB in lung adenocarcinoma cancer cells: The effect of combining RNA interferences with a chemical inhibitor.
Zarredar H; Pashapour S; Farajnia S; Ansarin K; Baradaran B; Ahmadzadeh V; Safari F
J Cell Biochem; 2019 Jun; 120(6):10670-10677. PubMed ID: 30656741
[TBL] [Abstract][Full Text] [Related]
8. Ca2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation.
Ishiguro K; Green T; Rapley J; Wachtel H; Giallourakis C; Landry A; Cao Z; Lu N; Takafumi A; Goto H; Daly MJ; Xavier RJ
Mol Cell Biol; 2006 Jul; 26(14):5497-508. PubMed ID: 16809782
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of endogenous heat shock protein 70 attenuates inducible nitric oxide synthase induction via disruption of heat shock protein 70/Na(+) /H(+) exchanger 1-Ca(2+) -calcium-calmodulin-dependent protein kinase II/transforming growth factor β-activated kinase 1-nuclear factor-κB signals in BV-2 microglia.
Huang C; Lu X; Wang J; Tong L; Jiang B; Zhang W
J Neurosci Res; 2015 Aug; 93(8):1192-202. PubMed ID: 25691123
[TBL] [Abstract][Full Text] [Related]
10. Blockade of L-type Ca
Ikeda S; Matsushima S; Okabe K; Ikeda M; Ishikita A; Tadokoro T; Enzan N; Yamamoto T; Sada M; Deguchi H; Morimoto S; Ide T; Tsutsui H
Sci Rep; 2019 Jul; 9(1):9850. PubMed ID: 31285514
[TBL] [Abstract][Full Text] [Related]
11. Clozapine reduces Toll-like receptor 4/NF-κB-mediated inflammatory responses through inhibition of calcium/calmodulin-dependent Akt activation in microglia.
Jeon S; Kim SH; Shin SY; Lee YH
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():477-487. PubMed ID: 28431901
[TBL] [Abstract][Full Text] [Related]
12. Evidence for unique calmodulin-dependent nuclear factor-kappaB regulation in WEHI-231 B cells.
Shumway SD; Berchtold CM; Gould MN; Miyamoto S
Mol Pharmacol; 2002 Jan; 61(1):177-85. PubMed ID: 11752219
[TBL] [Abstract][Full Text] [Related]
13. Kruppel-like factor 4 inhibits non-small cell lung cancer cell growth and aggressiveness by stimulating transforming growth factor-β1-meidated ERK/JNK/NF-κB signaling pathways.
Yu R; Han L; Ni X; Wang M; Xue P; Zhang L; Yuan M
Tumour Biol; 2017 Jun; 39(6):1010428317705574. PubMed ID: 28631556
[TBL] [Abstract][Full Text] [Related]
14. Interaction of calmodulin with Bcl10 modulates NF-kappaB activation.
Edin S; Oruganti SR; Grundström C; Grundström T
Mol Immunol; 2010 Jul; 47(11-12):2057-64. PubMed ID: 20439115
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of NF-κB inducing kinase underlies constitutive NF-κB activation in lung cancer cells.
Saitoh Y; Martínez Bruyn VJ; Uota S; Hasegawa A; Yamamoto N; Imoto I; Inazawa J; Yamaoka S
Lung Cancer; 2010 Dec; 70(3):263-70. PubMed ID: 20338663
[TBL] [Abstract][Full Text] [Related]
16. Differential functional properties of calmodulin-dependent protein kinase IIgamma variants isolated from smooth muscle.
Gangopadhyay SS; Barber AL; Gallant C; Grabarek Z; Smith JL; Morgan KG
Biochem J; 2003 Jun; 372(Pt 2):347-57. PubMed ID: 12603201
[TBL] [Abstract][Full Text] [Related]
17. Lenvatinib Inhibits AKT/NF-κB Signaling and Induces Apoptosis Through Extrinsic/Intrinsic Pathways in Non-small Cell Lung Cancer.
Liu YC; Huang BH; Chung JG; Liu WL; Hsu FT; Lin SS
Anticancer Res; 2021 Jan; 41(1):123-130. PubMed ID: 33419805
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying the anti-inflammatory effects of the Ca2+/calmodulin antagonist CV-159 in cultured vascular smooth muscle cells.
Usui T; Yamawaki H; Kamibayashi M; Okada M; Hara Y
J Pharmacol Sci; 2010; 113(3):214-23. PubMed ID: 20562516
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo.
Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE
Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
